Literature DB >> 15927713

Ghrelin blunted vascular calcification in vivo and in vitro in rats.

Gui-Zhong Li1, Wei Jiang, Jing Zhao, Chun-Shui Pan, Jun Cao, Chao-Shu Tang, Lin Chang.   

Abstract

Ghrelin is a new peptide with regulatory actions in growth hormone secretion in the anterior pituitary gland and in energy metabolism. Currently, ghrelin has potently protective effects in cardiovascular diseases. We used an in vivo model of rat vascular calcification induced by vitamin D3 and nicotine and one of cultured rat vascular smooth muscular cells (VSMCs) calcification induced by beta-glycerophosphate to study the possible mechanism in the regulatory action of ghrelin in vascular calcification. Calcification increased total Ca2+ content and 45Ca2+ deposition in aortas and VSMCs and alkaline phosphatase (ALP) activation in plasma, aortas and VSMCs. However, calcified aortas and VSMCs showed a significant decrease in osteopontin (OPN) mRNA expression and a marked reduction of ghrelin levels in plasma and its mRNA expression in aortas. The aortic calcification was significantly attenuated by subcutaneous administration of ghrelin 30 and 300 nmol kg(-1) day(-1) for 4 weeks, and the latter dosage was more potent than the former. Ghrelin treatment at the two dosages reduced the total aorta Ca2+ content by 24.4% and 28.1%, aortic 45Ca2+ deposition by 18.4% and 24.9%, plasma ALP activity by 36.6% and 76.7%, and aortic ALP activity by 10.3% and 47.6% (all P < 0.01 or 0.05), respectively. Ghrelin at 10(-8)-10(-6) mol/L attenuated the calcification in cultured VSMCs, with decreased total Ca2+ content, 45Ca2+ deposition and ALP activity and increased OPN mRNA expression, in a concentration-dependent manner. In addition, endothelin levels in plasma and aortas and its mRNA expression in aortas significantly increased with calcification, but ghrelin treatment significantly decreased endothelin levels and mRNA expression, with the high dosage being more potent than the lower dosage. These results indicate that local ghrelin in vascular was down-regulated during vascular calcification, whereas administration of ghrelin effectively attenuated vascular and VSMCs calcification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927713     DOI: 10.1016/j.regpep.2005.02.015

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

1.  C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels.

Authors:  Jing-Jing Chen; Jing Zhang; Yan Cai; Ye-Bo Zhou; Ge-Bo Wen; Chao-Shu Tang; Yong-Fen Qi; Zhi-Sheng Jiang
Journal:  Mol Cell Biochem       Date:  2014-04-08       Impact factor: 3.396

2.  Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway.

Authors:  Yan Cai; Xu Teng; Chun-shui Pan; Xiao-hui Duan; Chao-shu Tang; Yong-fen Qi
Journal:  Acta Pharmacol Sin       Date:  2010-08-30       Impact factor: 6.150

3.  Ghrelin and cardiovascular diseases.

Authors:  Gaigai Zhang; Xinhua Yin; Yongfen Qi; Lakshmana Pendyala; Jack Chen; Dongming Hou; Chaoshu Tang
Journal:  Curr Cardiol Rev       Date:  2010-02

Review 4.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

5.  Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; María J Gil; Fernando Rotellar; Secundino Fernández; Javier Salvador; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Surg Endosc       Date:  2014-03-13       Impact factor: 4.584

6.  Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway.

Authors:  Qiu-Hua Liang; Yi Jiang; Xiao Zhu; Rong-Rong Cui; Guan-Ying Liu; Yuan Liu; Shan-Shan Wu; Xiao-Bo Liao; Hui Xie; Hou-De Zhou; Xian-Ping Wu; Ling-Qing Yuan; Er-Yuan Liao
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 7.  Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.

Authors:  Joshua P H Neale; James T Pearson; Rajesh Katare; Daryl O Schwenke
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-13       Impact factor: 5.555

8.  Regional Differences in the Ghrelin-Growth Hormone Secretagogue Receptor Signalling System in Human Heart Disease.

Authors:  Rebecca Sullivan; Varinder K Randhawa; Tyler Lalonde; Tina Yu; Bob Kiaii; Leonard Luyt; Gerald Wisenberg; Savita Dhanvantari
Journal:  CJC Open       Date:  2020-11-04

9.  IL-18 Mediates Vascular Calcification Induced by High-Fat Diet in Rats With Chronic Renal Failure.

Authors:  Yinyin Zhang; Kun Zhang; Yuling Zhang; Lingqu Zhou; Hui Huang; Jingfeng Wang
Journal:  Front Cardiovasc Med       Date:  2021-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.